These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 12500202)
1. Cyclooxygenase-derived products modulate the increased intrahepatic resistance of cirrhotic rat livers. Graupera M; García-Pagán JC; Abraldes JG; Peralta C; Bragulat M; Corominola H; Bosch J; Rodés J Hepatology; 2003 Jan; 37(1):172-81. PubMed ID: 12500202 [TBL] [Abstract][Full Text] [Related]
2. Sinusoidal endothelial COX-1-derived prostanoids modulate the hepatic vascular tone of cirrhotic rat livers. Graupera M; March S; Engel P; Rodés J; Bosch J; García-Pagán JC Am J Physiol Gastrointest Liver Physiol; 2005 Apr; 288(4):G763-70. PubMed ID: 15550559 [TBL] [Abstract][Full Text] [Related]
3. Deficit in nitric oxide production in cirrhotic rat livers is located in the sinusoidal and postsinusoidal areas. Loureiro-Silva MR; Cadelina GW; Groszmann RJ Am J Physiol Gastrointest Liver Physiol; 2003 Apr; 284(4):G567-74. PubMed ID: 12490431 [TBL] [Abstract][Full Text] [Related]
5. Nitroflurbiprofen, a nitric oxide-releasing cyclooxygenase inhibitor, improves cirrhotic portal hypertension in rats. Laleman W; Van Landeghem L; Van der Elst I; Zeegers M; Fevery J; Nevens F Gastroenterology; 2007 Feb; 132(2):709-19. PubMed ID: 17258737 [TBL] [Abstract][Full Text] [Related]
6. Cyclooxygenase-1 inhibition corrects endothelial dysfunction in cirrhotic rat livers. Graupera M; García-Pagán JC; Parés M; Abraldes JG; Roselló J; Bosch J; Rodés J J Hepatol; 2003 Oct; 39(4):515-21. PubMed ID: 12971960 [TBL] [Abstract][Full Text] [Related]
7. Kupffer cell depletion attenuates leptin-mediated methoxamine-stimulated portal perfusion pressure and thromboxane A2 release in a rodent model of NASH-cirrhosis. Yang YY; Huang YT; Tsai TH; Hou MC; Lee FY; Lee SD; Lin HC Clin Sci (Lond); 2012 Dec; 123(12):669-80. PubMed ID: 22734967 [TBL] [Abstract][Full Text] [Related]
9. Endothelial dysfunction and decreased production of nitric oxide in the intrahepatic microcirculation of cirrhotic rats. Gupta TK; Toruner M; Chung MK; Groszmann RJ Hepatology; 1998 Oct; 28(4):926-31. PubMed ID: 9755227 [TBL] [Abstract][Full Text] [Related]
10. Simvastatin effects on portal-systemic collaterals of portal hypertensive rats. Huang HC; Wang SS; Lee JY; Chen YC; Lee FY; Lin HC; Chang CC; Lee SD J Gastroenterol Hepatol; 2010 Aug; 25(8):1401-9. PubMed ID: 20659230 [TBL] [Abstract][Full Text] [Related]
11. Evidence against a role for NADPH oxidase modulating hepatic vascular tone in cirrhosis. Gracia-Sancho J; Laviña B; Rodríguez-Vilarrupla A; Brandes RP; Fernández M; Bosch J; García-Pagán JC Gastroenterology; 2007 Sep; 133(3):959-66. PubMed ID: 17854599 [TBL] [Abstract][Full Text] [Related]
12. Cyclooxygenase-2 inhibition improves vascular endothelial dysfunction in a rat model of endotoxic shock: role of inducible nitric-oxide synthase and oxidative stress. Virdis A; Colucci R; Fornai M; Blandizzi C; Duranti E; Pinto S; Bernardini N; Segnani C; Antonioli L; Taddei S; Salvetti A; Del Tacca M J Pharmacol Exp Ther; 2005 Mar; 312(3):945-53. PubMed ID: 15547110 [TBL] [Abstract][Full Text] [Related]
13. Roles of anandamide in the hepatic microcirculation in cirrhotic rats. Yang YY; Lin HC; Huang YT; Lee TY; Hou MC; Wang YW; Lee FY; Lee SD Am J Physiol Gastrointest Liver Physiol; 2006 Feb; 290(2):G328-34. PubMed ID: 16407591 [TBL] [Abstract][Full Text] [Related]
14. Influence of nitric oxide synthase and cyclooxygenase blockade on expression of cyclooxygenase and hemodynamics in rats with portal hypertension. Cao H; Xu J; Liu H; Meng FB; Qiu JF; Wu ZY Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):564-9. PubMed ID: 17085343 [TBL] [Abstract][Full Text] [Related]
15. Kupffer cell activation in normal and fibrotic livers increases portal pressure via thromboxane A(2). Steib CJ; Gerbes AL; Bystron M; Op den Winkel M; Härtl J; Roggel F; Prüfer T; Göke B; Bilzer M J Hepatol; 2007 Aug; 47(2):228-38. PubMed ID: 17573142 [TBL] [Abstract][Full Text] [Related]
16. Dual functionality of cyclooxygenase-2 as a regulator of tumor necrosis factor-mediated G1 shortening and nitric oxide-mediated inhibition of vascular smooth muscle cell proliferation. Haider A; Lee I; Grabarek J; Darzynkiewicz Z; Ferreri NR Circulation; 2003 Aug; 108(8):1015-21. PubMed ID: 12912810 [TBL] [Abstract][Full Text] [Related]
17. Increased phosphodiesterase-5 expression is involved in the decreased vasodilator response to nitric oxide in cirrhotic rat livers. Loureiro-Silva MR; Iwakiri Y; Abraldes JG; Haq O; Groszmann RJ J Hepatol; 2006 May; 44(5):886-93. PubMed ID: 16545481 [TBL] [Abstract][Full Text] [Related]
19. Increased pulmonary vascular contraction to serotonin after cardiopulmonary bypass: role of cyclooxygenase. Sato K; Li J; Metais C; Bianchi C; Sellke F J Surg Res; 2000 May; 90(2):138-43. PubMed ID: 10792954 [TBL] [Abstract][Full Text] [Related]
20. Role of thromboxane A2 in early BDL-induced portal hypertension. Yokoyama Y; Xu H; Kresge N; Keller S; Sarmadi AH; Baveja R; Clemens MG; Zhang JX Am J Physiol Gastrointest Liver Physiol; 2003 Mar; 284(3):G453-60. PubMed ID: 12431905 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]